LIFELINE SPAC I OYJ A EO1
Canatu Oyj develops and sells carbon nanotubes (CNTs) and related products for the semiconductor, automotive, and medical diagnostics industries in Finland, the United States, Japan, and Taiwan. The company offers custom CNT synthesis reactors; CNT membrane for high-power EUV lithography and X-Ray filter applications; EUV pellicies to protect photomask for contamination while permitting high EUV … Read more
LIFELINE SPAC I OYJ A EO1 (0CD) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, LIFELINE SPAC I OYJ A EO1 (0CD) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
LIFELINE SPAC I OYJ A EO1 - Net Assets Trend (None–None)
This chart illustrates how LIFELINE SPAC I OYJ A EO1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LIFELINE SPAC I OYJ A EO1 (None–None)
The table below shows the annual net assets of LIFELINE SPAC I OYJ A EO1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to LIFELINE SPAC I OYJ A EO1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
LIFELINE SPAC I OYJ A EO1 Competitors by Market Cap
The table below lists competitors of LIFELINE SPAC I OYJ A EO1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
1ED
F:1ED
|
$254.84 Million |
|
Sophia Genetics SA
NASDAQ:SOPH
|
$254.89 Million |
|
ENCE Energía y Celulosa S.A
MC:ENC
|
$254.91 Million |
|
Moura Dubeux Engenharia S.A
SA:MDNE3
|
$254.94 Million |
|
Shenzhen SDG Service Co. Ltd.
SHE:300917
|
$254.69 Million |
|
Solutions 30 SE
PINK:SLUNF
|
$254.67 Million |
|
JK Paper Limited
NSE:JKPAPER
|
$254.63 Million |
|
Ocwen Financial Corp.
LSE:0KAS
|
$254.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LIFELINE SPAC I OYJ A EO1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares LIFELINE SPAC I OYJ A EO1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently LIFELINE SPAC I OYJ A EO1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares LIFELINE SPAC I OYJ A EO1's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $18,803,803,535
- Average return on equity (ROE) among peers: -24.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LIFELINE SPAC I OYJ A EO1 (0CD) | €- | N/A | N/A | $254.82 Million |
| Kureha Corporation (0K1) | $162.17 Billion | 8.59% | 0.53x | $845.56 Million |
| Polwax S.A (1LW) | $54.23 Million | -71.97% | 1.06x | $3.33 Million |
| H&R GmbH & Co. KGaA (2HRA) | $287.13 Million | 9.37% | 1.19x | $34.48 Million |
| Renaissance Oil Corp (2R7) | $2.68 Billion | 6.64% | 1.08x | $1.31 Billion |
| Global New Material International Holdings Limited (69Y) | $4.35 Billion | 5.56% | 0.62x | $625.83 Million |
| Altech Chemicals Ltd (A3Y) | $33.88 Million | -176.29% | 0.32x | $18.88 Million |
| Beijing Media Corporation Limited (BME) | $1.20 Billion | -7.10% | 0.16x | $1.77 Million |
| BRAIN Biotech AG (BNN) | $17.59 Million | -23.28% | 0.43x | $40.42 Million |
| Brenntag SE (BNR) | $2.69 Billion | 13.57% | 1.59x | $5.87 Billion |
| Huabao International Holdings Limited (CEY) | $14.56 Billion | -7.24% | 0.14x | $1.44 Billion |